A share price of Citius Pharmaceuticals Inc [CTXR] is currently trading at $1.45, down -2.03%. An important factor to consider is whether the stock is rising or falling in short-term value. The CTXR shares have gain 17.89% over the last week, with a monthly amount glided 23.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Citius Pharmaceuticals Inc [NASDAQ: CTXR] stock has seen the most recent analyst activity on December 30, 2024, when D. Boral Capital upgraded its rating to a Buy but kept the price target unchanged to $9 for it. Previously, Maxim Group started tracking the stock with Buy rating on November 30, 2021, and set its price target to $4.
Citius Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.65 and $12.84. Citius Pharmaceuticals Inc [NASDAQ: CTXR] shares were valued at $1.45 at the most recent close of the market.
Analyzing the CTXR fundamentals
Gross Profit Margin for this corporation currently stands at -1.32% with Operating Profit Margin at -263.84%, Pretax Profit Margin comes in at -263.82%, and Net Profit Margin reading is -258.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.62 and Total Capital is -0.54. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3600 points at the first support level, and at 1.2700 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5100, and for the 2nd resistance point, it is at 1.5700.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Citius Pharmaceuticals Inc [NASDAQ:CTXR] is 0.47. On the other hand, the Quick Ratio is 0.14, and the Cash Ratio is 0.12.
